← Leaderboards
Jeffrey Pelletier
Neurokine Therapeutics, Llc
$1,196,626
Attributed
$2,393,251
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$2,393,251 · 1
By mechanism
R44$2,393,251 · 1
Top collaborators
- Lawrence S Honig2 shared
Most similar at Neurokine Therapeutics, Llc
Same institution · by research overlap
- Lawrence S Honig$14,558,257
- Wayne F Anderson$250,000
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposNeurogliaClinical DevelopmentHandMolecular Drug TargetNervous System DisorderCovid-19 PandemicDrug ExposureExhibitsFutureCommercializationBrainMonitorCapsuleDrug KineticsAmyloidClinical ResearchClinical Research SiteClinical TreatmentElementsFoundationsFunctional DisorderInvestmentsNeuroinflammation